US university says common FDA-approved drug may effectively neutralise SARS-CoV-2 virus

This article was originally published here

SARS-CoV-2, the virus that causes COVID-19, uses a surface spike protein to latch onto human cells and initiate infection. But heparin, a blood thinner also available in non-anticoagulant

The post US university says common FDA-approved drug may effectively neutralise SARS-CoV-2 virus appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply